Literature DB >> 18597479

The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding.

Bipul R Acharya1, Bhabatarak Bhattacharyya, Gopal Chakrabarti.   

Abstract

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), a naphthoquinone isolated from the roots of Plumbaginaceae plants, has potential antiproliferative activity against several tumor types. We have examined the effects of plumbagin on cellular microtubules ex vivo as well as its binding with purified tubulin and microtubules in vitro. Cell viability experiments using human non-small lung epithelium carcinoma cells (A549) indicated that the IC 50 value for plumbagin is 14.6 microM. Immunofluorescence studies using an antitubulin FITC conjugated antibody showed a significant perturbation of the interphase microtubule network in a dose dependent manner. In vitro polymerization of purified tubulin into microtubules is inhibited by plumbagin with an IC 50 value of 38 +/- 0.5 microM. Its binding to tubulin quenches protein tryptophan fluorescence in a time and concentration dependent manner. Binding of plumbagin to tubulin is slow, taking 60 min for equilibration at 25 degrees C. The association reaction kinetics is biphasic in nature, and the association rate constants for fast and slow phases are 235.12 +/- 36 M (-1) s (-1) and 11.63 +/- 11 M (-1) s (-1) at 25 degrees C respectively. The stoichiometry of plumbagin binding to tubulin is 1:1 (mole:mole) with a dissociation constant of 0.936 +/- 0.71 microM at 25 degrees C. Plumbagin competes for the colchicine binding site with a K i of 7.5 microM as determined from a modified Dixon plot. Based on these data we conclude that plumbagin recognizes the colchicine binding site to tubulin. Further study is necessary to locate the pharmacophoric point of attachment of the inhibitor to the colchicine binding site of tubulin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18597479     DOI: 10.1021/bi800730q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin.

Authors:  Kodihalli C Ravindra; B Ruthrotha Selvi; Mohammed Arif; B A Ashok Reddy; Gali R Thanuja; Shipra Agrawal; Suman Kalyan Pradhan; Natesh Nagashayana; Dipak Dasgupta; Tapas K Kundu
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

2.  Proteomics analyses of Bacillus subtilis after treatment with plumbagin, a plant-derived naphthoquinone.

Authors:  Panga Jaipal Reddy; Sandipan Ray; Gajanan J Sathe; T S Keshava Prasad; Srikanth Rapole; Dulal Panda; Sanjeeva Srivastava
Journal:  OMICS       Date:  2015-01

3.  Synthesis and cytotoxic activities of some 2-arylnaphtho[2,3-d]oxazole-4,9-dione derivatives on androgen-dependent (LNCaP) and androgen-independent (PC3) human prostate cancer cell lines.

Authors:  Yakini Brandy; Innocent Ononiwu; Dolapo Adedeji; Vonetta Williams; Claudia Mouamba; Yasmine Kanaan; Robert L Copeland; Dwayne A Wright; Ray J Butcher; Samuel R Denmeade; Oladapo Bakare
Journal:  Invest New Drugs       Date:  2011-01-18       Impact factor: 3.850

4.  Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells.

Authors:  Jiunn-Min Shieh; Tai-An Chiang; Wen-Teng Chang; Chang-Hung Chao; Yi-Chieh Lee; Guan-Yu Huang; You-Xin Shih; Yuan-Wei Shih
Journal:  Mol Cell Biochem       Date:  2009-09-21       Impact factor: 3.396

Review 5.  Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.

Authors:  Krupanandan Haranahalli; Simon Tong; Iwao Ojima
Journal:  Bioorg Med Chem       Date:  2016-05-05       Impact factor: 3.641

6.  Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin.

Authors:  Igor Alves Mancilla; Giuliana Castello Coatti; Bruna Isabela Biazi; Thalita Alves Zanetti; Adrivanio Baranoski; Lilian Areal Marques; Amanda Cristina Corveloni; Sandra Regina Lepri; Mario Sergio Mantovani
Journal:  Mol Biol Rep       Date:  2019-08-27       Impact factor: 2.316

7.  The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice.

Authors:  Sayan Chowdhury; Tulika Mukherjee; Rupkatha Mukhopadhyay; Budhaditya Mukherjee; Souvik Sengupta; Sharmila Chattopadhyay; Parasuraman Jaisankar; Syamal Roy; Hemanta K Majumder
Journal:  EMBO Mol Med       Date:  2012-10       Impact factor: 12.137

8.  Synthesis and characterization of novel unsymmetrical and symmetrical 3-halo- or 3-methoxy-substituted 2-dibenzoylamino-1,4-naphthoquinone derivatives.

Authors:  Yakini Brandy; Nailah Brandy; Emmanuel Akinboye; Malik Lewis; Claudia Mouamba; Seshat Mack; Ray J Butcher; Alan J Anderson; Oladapo Bakare
Journal:  Molecules       Date:  2013-02-04       Impact factor: 4.411

9.  Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure Cancer.

Authors:  François Gaascht; Mario Dicato; Marc Diederich
Journal:  Front Oncol       Date:  2013-08-20       Impact factor: 6.244

10.  Anticancer compound plumbagin and its molecular targets: a structural insight into the inhibitory mechanisms using computational approaches.

Authors:  Mohammad S Jamal; Shadma Parveen; Mohd A Beg; Mohd Suhail; Adeel G A Chaudhary; Ghazi A Damanhouri; Adel M Abuzenadah; Mohd Rehan
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.